AGM/EGMApr 30, 2026, 04:14 PM
MNPR Annual Meeting Set for June 22, 2026; 2026 Stock Plan Proposed
AI Summary
Monopar Therapeutics Inc. announced its Annual Meeting of Stockholders to be held on June 22, 2026. Stockholders will consider and vote on the election of six directors, an advisory resolution on executive compensation, the approval of the Company's 2026 Stock Incentive Plan, and the ratification of BPM LLP as the independent registered public accounting firm. The 2026 Stock Incentive Plan proposes to add 600,000 new shares, representing 9.2% of the fully-diluted common stock outstanding. The Board of Directors unanimously recommends voting "FOR" all proposals.
Key Highlights
- Annual Meeting of Stockholders scheduled for June 22, 2026, at 10:00am Central Time.
- Stockholders to vote on the election of six directors, including new nominee Nicole Sweeny.
- Advisory, non-binding vote on the compensation of named executive officers (NEOs).
- Approval of the 2026 Stock Incentive Plan, adding 600,000 new shares.
- New shares under the 2026 Plan represent 9.2% of fully-diluted common stock outstanding.
- Ratification of BPM LLP as the independent registered public accounting firm for 2026.
- Board of Directors unanimously recommends voting "FOR" all proposals.
Price Impact
More from MNPR